AEDIFICA (AED.BR) Stock Fundamental Analysis

Europe • Euronext Brussels • EBR:AED • BE0003851681

74.2 EUR
+0.25 (+0.34%)
Last: Feb 3, 2026, 07:00 PM
Fundamental Rating

4

We assign a fundamental rating of 4 out of 10 to AED. AED was compared to 42 industry peers in the Diversified REITs industry. AED has a medium profitability rating, but doesn't score so well on its financial health evaluation. While showing a medium growth rate, AED is valued expensive at the moment.


Dividend Valuation Growth Profitability Health

6

1. Profitability

1.1 Basic Checks

  • In the past year AED was profitable.
  • In the past year AED had a positive cash flow from operations.
  • In the past 5 years AED has always been profitable.
  • Each year in the past 5 years AED had a positive operating cash flow.
AED.BR Yearly Net Income VS EBIT VS OCF VS FCFAED.BR Yearly Net Income VS EBIT VS OCF VS FCFYearly Net Income VS EBIT VS OCF VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M

1.2 Ratios

  • AED has a Return On Assets (2.73%) which is comparable to the rest of the industry.
  • The Return On Equity of AED (4.96%) is comparable to the rest of the industry.
  • AED has a Return On Invested Capital of 3.52%. This is comparable to the rest of the industry: AED outperforms 57.14% of its industry peers.
  • AED had an Average Return On Invested Capital over the past 3 years of 3.33%. This is in line with the industry average of 3.37%.
  • The last Return On Invested Capital (3.52%) for AED is above the 3 year average (3.33%), which is a sign of increasing profitability.
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROIC 3.52%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
AED.BR Yearly ROA, ROE, ROICAED.BR Yearly ROA, ROE, ROICYearly ROA, ROE, ROIC 2016 2017 2018 2019 2020 2021 2022 2023 2024 2 4 6 8 10

1.3 Margins

  • Looking at the Profit Margin, with a value of 49.82%, AED is in the better half of the industry, outperforming 66.67% of the companies in the same industry.
  • In the last couple of years the Profit Margin of AED has declined.
  • Looking at the Operating Margin, with a value of 77.70%, AED is in the better half of the industry, outperforming 71.43% of the companies in the same industry.
  • In the last couple of years the Operating Margin of AED has remained more or less at the same level.
  • AED's Gross Margin of 97.93% is amongst the best of the industry. AED outperforms 97.62% of its industry peers.
  • AED's Gross Margin has been stable in the last couple of years.
Industry RankSector Rank
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
AED.BR Yearly Profit, Operating, Gross MarginsAED.BR Yearly Profit, Operating, Gross MarginsYearly Profit, Operating, Gross Margins 2016 2017 2018 2019 2020 2021 2022 2023 2024 20 40 60 80 100

2

2. Health

2.1 Basic Checks

  • The Return on Invested Capital (ROIC) is below the Cost of Capital (WACC), so AED is destroying value.
  • Compared to 1 year ago, AED has about the same amount of shares outstanding.
  • Compared to 5 years ago, AED has more shares outstanding
  • The debt/assets ratio for AED is higher compared to a year ago.
AED.BR Yearly Shares OutstandingAED.BR Yearly Shares OutstandingYearly Shares Outstanding 2016 2017 2018 2019 2020 2021 2022 2023 2024 10M 20M 30M 40M
AED.BR Yearly Total Debt VS Total AssetsAED.BR Yearly Total Debt VS Total AssetsYearly Total Debt VS Total Assets 2016 2017 2018 2019 2020 2021 2022 2023 2024 2B 4B 6B

2.2 Solvency

  • AED has an Altman-Z score of 0.89. This is a bad value and indicates that AED is not financially healthy and even has some risk of bankruptcy.
  • Looking at the Altman-Z score, with a value of 0.89, AED is in line with its industry, outperforming 54.76% of the companies in the same industry.
  • The Debt to FCF ratio of AED is 24.91, which is on the high side as it means it would take AED, 24.91 years of fcf income to pay off all of its debts.
  • AED has a Debt to FCF ratio of 24.91. This is in the lower half of the industry: AED underperforms 66.67% of its industry peers.
  • A Debt/Equity ratio of 0.58 indicates that AED is somewhat dependend on debt financing.
  • The Debt to Equity ratio of AED (0.58) is better than 66.67% of its industry peers.
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Altman-Z 0.89
ROIC/WACC0.57
WACC6.22%
AED.BR Yearly LT Debt VS Equity VS FCFAED.BR Yearly LT Debt VS Equity VS FCFYearly LT Debt VS Equity VS FCF 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 1B 2B 3B

2.3 Liquidity

  • AED has a Current Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • AED has a Current ratio (0.35) which is in line with its industry peers.
  • AED has a Quick Ratio of 0.35. This is a bad value and indicates that AED is not financially healthy enough and could expect problems in meeting its short term obligations.
  • With a Quick ratio value of 0.35, AED perfoms like the industry average, outperforming 47.62% of the companies in the same industry.
Industry RankSector Rank
Current Ratio 0.35
Quick Ratio 0.35
AED.BR Yearly Current Assets VS Current LiabilitesAED.BR Yearly Current Assets VS Current LiabilitesYearly Current Assets VS Current Liabilites 2016 2017 2018 2019 2020 2021 2022 2023 2024 200M 400M 600M

6

3. Growth

3.1 Past

  • AED shows a strong growth in Earnings Per Share. In the last year, the EPS has been growing by 114.94%, which is quite impressive.
  • Measured over the past years, AED shows a decrease in Earnings Per Share. The EPS has been decreasing by -7.20% on average per year.
  • The Revenue has grown by 8.06% in the past year. This is quite good.
  • AED shows a strong growth in Revenue. Measured over the last years, the Revenue has been growing by 23.35% yearly.
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%

3.2 Future

  • The Earnings Per Share is expected to grow by 3.19% on average over the next years.
  • The Revenue is expected to grow by 5.12% on average over the next years.
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A

3.3 Evolution

  • The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
  • When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
AED.BR Yearly Revenue VS EstimatesAED.BR Yearly Revenue VS EstimatesYearly Revenue VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 100M 200M 300M
AED.BR Yearly EPS VS EstimatesAED.BR Yearly EPS VS EstimatesYearly EPS VS Estimates 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025 2026 2027 1 2 3 4 5

2

4. Valuation

4.1 Price/Earnings Ratio

  • AED is valuated correctly with a Price/Earnings ratio of 15.49.
  • AED's Price/Earnings is on the same level as the industry average.
  • The average S&P500 Price/Earnings ratio is at 28.18. AED is valued slightly cheaper when compared to this.
  • Based on the Price/Forward Earnings ratio of 14.12, the valuation of AED can be described as correct.
  • 64.29% of the companies in the same industry are cheaper than AED, based on the Price/Forward Earnings ratio.
  • Compared to an average S&P500 Price/Forward Earnings ratio of 25.51, AED is valued a bit cheaper.
Industry RankSector Rank
PE 15.49
Fwd PE 14.12
AED.BR Price Earnings VS Forward Price EarningsAED.BR Price Earnings VS Forward Price Earnings ChartPrice Earnings - Forward Price Earnings PE FPE 5 10 15 20 25

4.2 Price Multiples

  • 61.90% of the companies in the same industry are cheaper than AED, based on the Enterprise Value to EBITDA ratio.
  • Based on the Price/Free Cash Flow ratio, AED is valued a bit more expensive than 78.57% of the companies in the same industry.
Industry RankSector Rank
P/FCF 34.04
EV/EBITDA 21.77
AED.BR Per share dataAED.BR EPS, Sales, OCF, FCF, BookValue per sharePer Share Data Per Share 20 40 60

4.3 Compensation for Growth

  • The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates AED does not grow enough to justify the current Price/Earnings ratio.
  • AED has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)3.72
PEG (5Y)N/A
EPS Next 2Y3.32%
EPS Next 3Y3.19%

3

5. Dividend

5.1 Amount

  • With a Yearly Dividend Yield of 3.76%, AED has a reasonable but not impressive dividend return.
  • AED's Dividend Yield is slightly below the industry average, which is at 5.30.
  • Compared to an average S&P500 Dividend Yield of 1.83, AED pays a better dividend.
Industry RankSector Rank
Dividend Yield 3.76%

5.2 History

  • On average, the dividend of AED grows each year by 22.82%, which is quite nice.
Dividend Growth(5Y)22.82%
Div Incr Years1
Div Non Decr Years1
AED.BR Yearly Dividends per shareAED.BR Yearly Dividends per shareYearly Dividends per share 2018 2019 2020 2021 2022 2023 2024 2025 1 2 3 4 5

5.3 Sustainability

  • 105.58% of the earnings are spent on dividend by AED. This is not a sustainable payout ratio.
  • AED's earnings are growing slower than its dividend. This means the dividend growth is not sustainable.
DP105.58%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
AED.BR Yearly Income VS Free CF VS DividendAED.BR Yearly Income VS Free CF VS DividendYearly Income VS Free CF VS Dividend 2016 2017 2018 2019 2020 2021 2022 2023 2024 0 200M -200M
AED.BR Dividend Payout.AED.BR Dividend Payout, showing the Payout Ratio.AED.BR Dividend Payout.PayoutRetained Earnings

AEDIFICA

EBR:AED (2/3/2026, 7:00:00 PM)

74.2

+0.25 (+0.34%)

Chartmill FA Rating
GICS SectorReal Estate
GICS IndustryGroupEquity Real Estate Investment Trusts (REITs)
GICS IndustryDiversified REITs
Earnings (Last)10-28
Earnings (Next)02-25
Inst Owners41.34%
Inst Owner ChangeN/A
Ins Owners0.11%
Ins Owner ChangeN/A
Market Cap3.53B
Revenue(TTM)358.28M
Net Income(TTM)175.81M
Analysts81.11
Price Target77.16 (3.99%)
Short Float %N/A
Short RatioN/A
Dividend
Industry RankSector Rank
Dividend Yield 3.76%
Yearly Dividend3.51
Dividend Growth(5Y)22.82%
DP105.58%
Div Incr Years1
Div Non Decr Years1
Ex-DateN/A
Surprises & Revisions
EPS beat(2)N/A
Avg EPS beat(2)N/A
Min EPS beat(2)N/A
Max EPS beat(2)N/A
EPS beat(4)N/A
Avg EPS beat(4)N/A
Min EPS beat(4)N/A
Max EPS beat(4)N/A
EPS beat(8)N/A
Avg EPS beat(8)N/A
EPS beat(12)N/A
Avg EPS beat(12)N/A
EPS beat(16)N/A
Avg EPS beat(16)N/A
Revenue beat(2)N/A
Avg Revenue beat(2)N/A
Min Revenue beat(2)N/A
Max Revenue beat(2)N/A
Revenue beat(4)N/A
Avg Revenue beat(4)N/A
Min Revenue beat(4)N/A
Max Revenue beat(4)N/A
Revenue beat(8)N/A
Avg Revenue beat(8)N/A
Revenue beat(12)N/A
Avg Revenue beat(12)N/A
Revenue beat(16)N/A
Avg Revenue beat(16)N/A
PT rev (1m)0.76%
PT rev (3m)2.97%
EPS NQ rev (1m)N/A
EPS NQ rev (3m)N/A
EPS NY rev (1m)0.62%
EPS NY rev (3m)0.73%
Revenue NQ rev (1m)N/A
Revenue NQ rev (3m)N/A
Revenue NY rev (1m)0%
Revenue NY rev (3m)0.32%
Valuation
Industry RankSector Rank
PE 15.49
Fwd PE 14.12
P/S 10
P/FCF 34.04
P/OCF 12.08
P/B 0.99
P/tB 1.02
EV/EBITDA 21.77
EPS(TTM)4.79
EY6.46%
EPS(NY)5.26
Fwd EY7.08%
FCF(TTM)2.18
FCFY2.94%
OCF(TTM)6.14
OCFY8.28%
SpS7.42
BVpS74.59
TBVpS72.74
PEG (NY)3.72
PEG (5Y)N/A
Graham Number89.66
Profitability
Industry RankSector Rank
ROA 2.73%
ROE 4.96%
ROCE 4.69%
ROIC 3.52%
ROICexc 3.55%
ROICexgc 3.61%
OM 77.7%
PM (TTM) 49.82%
GM 97.93%
FCFM 29.37%
ROA(3y)3.01%
ROA(5y)3.48%
ROE(3y)5.47%
ROE(5y)6.57%
ROIC(3y)3.33%
ROIC(5y)3.26%
ROICexc(3y)3.34%
ROICexc(5y)3.28%
ROICexgc(3y)3.4%
ROICexgc(5y)3.38%
ROCE(3y)4.43%
ROCE(5y)4.34%
ROICexgc growth 3Y6.29%
ROICexgc growth 5Y0.95%
ROICexc growth 3Y7%
ROICexc growth 5Y0.65%
OM growth 3Y1.55%
OM growth 5Y0.91%
PM growth 3Y-20.75%
PM growth 5Y-10.29%
GM growth 3Y0.24%
GM growth 5Y0.4%
F-Score7
Asset Turnover0.05
Health
Industry RankSector Rank
Debt/Equity 0.58
Debt/FCF 24.91
Debt/EBITDA 7.41
Cap/Depr 6078.86%
Cap/Sales 53.38%
Interest Coverage 250
Cash Conversion 105.31%
Profit Quality 58.95%
Current Ratio 0.35
Quick Ratio 0.35
Altman-Z 0.89
F-Score7
WACC6.22%
ROIC/WACC0.57
Cap/Depr(3y)11089%
Cap/Depr(5y)16628.2%
Cap/Sales(3y)126.51%
Cap/Sales(5y)150.79%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)114.94%
EPS 3Y-18.35%
EPS 5Y-7.2%
EPS Q2Q%180.79%
EPS Next Y4.17%
EPS Next 2Y3.32%
EPS Next 3Y3.19%
EPS Next 5YN/A
Revenue 1Y (TTM)8.06%
Revenue growth 3Y13.45%
Revenue growth 5Y23.35%
Sales Q2Q%6.32%
Revenue Next Year6.54%
Revenue Next 2Y5.49%
Revenue Next 3Y5.12%
Revenue Next 5YN/A
EBIT growth 1Y9.49%
EBIT growth 3Y15.21%
EBIT growth 5Y24.47%
EBIT Next Year10.51%
EBIT Next 3Y6.39%
EBIT Next 5YN/A
FCF growth 1Y142.07%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y18.63%
OCF growth 3Y7.82%
OCF growth 5Y22.86%

AEDIFICA / AED.BR FAQ

What is the fundamental rating for AED stock?

ChartMill assigns a fundamental rating of 4 / 10 to AED.BR.


What is the valuation status of AEDIFICA (AED.BR) stock?

ChartMill assigns a valuation rating of 2 / 10 to AEDIFICA (AED.BR). This can be considered as Overvalued.


How profitable is AEDIFICA (AED.BR) stock?

AEDIFICA (AED.BR) has a profitability rating of 6 / 10.


Can you provide the PE and PB ratios for AED stock?

The Price/Earnings (PE) ratio for AEDIFICA (AED.BR) is 15.49 and the Price/Book (PB) ratio is 0.99.


Can you provide the financial health for AED stock?

The financial health rating of AEDIFICA (AED.BR) is 2 / 10.